UBS Maintains Buy on XP, Raises Price Target to $28

UBS analyst Thiago Batista has reaffirmed a Buy rating on XP (NASDAQ: XP) and increased the price target from $25 to $28. This adjustment reflects a positive outlook for the company in the market.